Schooler, Nina R.
SUNY Downstate Health Sciences University
13 papers on CoChatORCID 0000-0003-3610-9393
Most cited papers
- Verified
Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment
Correll, C. U., & Schooler, N. R. (2020) · Neuropsychiatric Disease and Treatment
Schizophrenia research and treatmentMental Health and Psychiatry
Cited by 911
- Verified
Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression
Correll, C. U., Galling, B., Pawar, A., Krivko, A., Bonetto, C., Ruggeri, M., Craig, T. J., Nordentoft, M., Srihari, V. H., Guloksuz, S., et al. (2018) · JAMA Psychiatry
Schizophrenia research and treatmentPsychiatric care and mental health services
Cited by 826
- Verified
The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments
Buchanan, R. W., Javitt, D. C., Marder, S. R., Schooler, N. R., Gold, J. M., McMahon, R. P., Heresco-Levy, U., & Carpenter, W. T. (2007) · American Journal of Psychiatry
Schizophrenia research and treatmentAmino Acid Enzymes and Metabolism
Cited by 419
- Verified
Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders: Baseline Results From the RAISE-ETP Study
Correll, C. U., Robinson, D. G., Schooler, N. R., Brunette, M. F., Mueser, K. T., Rosenheck, R. A., Marcy, P., Addington, J., Estroff, S. E., Robinson, J., et al. (2014) · JAMA Psychiatry
Schizophrenia research and treatmentDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 384
- Verified
Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial
Kane, J. M., Schooler, N. R., Marcy, P., Correll, C. U., Achtyes, E. D., Gibbons, R. D., & Robinson, D. G. (2020) · JAMA psychiatry
Schizophrenia research and treatmentPsychiatric care and mental health services
Cited by 208
- Verified
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia
Green, M. F., Schooler, N. R., Kern, R. S., Frese, F. J., Granberry, W., Harvey, P. D., Karson, C. N., Peters, N., Stewart, M., Seidman, L. J., et al. (2011) · American Journal of Psychiatry
Schizophrenia research and treatmentPsychological Testing and Assessment
Cited by 159
- Verified
Adjunctive Divalproex Versus Placebo for Children With ADHD and Aggression Refractory to Stimulant Monotherapy
Blader, J. C., Schooler, N. R., Jensen, P. S., Pliszka, S. R., & Kafantaris, V. (2009) · American Journal of Psychiatry
Attention Deficit Hyperactivity DisorderBehavioral and Psychological Studies
Cited by 149
- Verified
Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far?
Keefe, R. S. E., Buchanan, R. W., Marder, S. R., Schooler, N. R., Dugar, A., Zivkov, M., & Stewart, M. (2013) · Schizophrenia Bulletin
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 138
- Verified
mHealth for Schizophrenia: Patient Engagement With a Mobile Phone Intervention Following Hospital Discharge
Ben-Zeev, D., Scherer, E. A., Gottlieb, J. D., Rotondi, A. J., Brunette, M. F., Achtyes, E. D., Mueser, K. T., Gingerich, S., Brenner, C. J., Begale, M., et al. (2016) · JMIR Mental Health
Digital Mental Health InterventionsMobile Health and mHealth Applications
Cited by 137
- Verified
Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication
Glazer, W. M., Morgenstern, H., Schooler, N., Berkman, C. S., & Moore, D. C. (1990) · British Journal of Psychiatry
Schizophrenia research and treatmentElectroconvulsive Therapy Studies
Cited by 106
- Verified
Stimulant-Responsive and Stimulant-Refractory Aggressive Behavior Among Children With ADHD
Blader, J. C., Pliszka, S. R., Jensen, P. S., Schooler, N. R., & Kafantaris, V. (2010) · Pediatrics
Attention Deficit Hyperactivity DisorderBehavioral and Psychological Studies
Cited by 106
- Verified · note
Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial
Kane, J. M., Schooler, N. R., Marcy, P., Achtyes, E. D., Correll, C. U., & Robinson, D. G. (2019) · The Journal of Clinical Psychiatry
Schizophrenia research and treatmentMedication Adherence and Compliance
Cited by 58
- Verified
Off-hours use of a smartphone intervention to extend support for individuals with schizophrenia spectrum disorders recently discharged from a psychiatric hospital
Achtyes, E. D., Ben-Zeev, D., Luo, Z., Mayle, H., Burke, B., Rotondi, A. J., Gottlieb, J. D., Brunette, M. F., Mueser, K. T., Gingerich, S., et al. (2019) · Schizophrenia Research
Digital Mental Health InterventionsMobile Health and mHealth Applications
Cited by 35
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free